Dicerna Pharmaceuticals, Inc., A Novo Nordisk Company

This study tested a drug called nedosiran in young children with primary hyperoxaluria, a rare genetic disease that causes the body to produce too much of a substance called oxalate. The oxalate can damage the kidneys and other organs. The main goal was to see if monthly doses of…

This early-stage study tested a new drug called DCR-STAT3 in adults with advanced solid tumors that had stopped responding to standard treatments. The main goal was to check the drug's safety and how the body processes it in 26 participants. Researchers also looked for early sign…

This early-stage study tested the safety of an experimental drug called DCR-AUD in healthy adults who are social drinkers. Researchers gave participants multiple doses to see how their bodies handled the drug and what side effects occurred, especially when combined with alcohol i…